In brief: Burns joins Progen; Cryptome appoints CSO
Monday, 23 August, 2004
Progen Industries (ASX: PGL, NASDAQ: PGLAF), announced today it had appointed former Bresagen chief financial officer and company secretary, Linton Burns, as CFO and company secretary.
Burns succeeds Milton McColl, has been Progen's CFO since late 2001.
And Melbourne-based Cryptome Pharmaceuticals (ASX: CRP) has appointed Dr Leodevico Ilag as chief scientific officer. Dr Ilag is the co-founder, former managing director and current chief technology officer of Munich proteomics company Xerion Pharmaceuticals. He is due to join Cryptome in September 2004.
Cancer drug enters clinical trials based on a false mechanism
A cancer drug currently being tested in patients appears to have entered clinical trials based on...
Russia insists there is "no plague case" following lab worker death
Russian health authorities say there is no evidence that pneumonic plague played a part in the...
Scientists 'reprogram' tumour-supporting immune cells
The approach, by an Australian team, uses lipid nanoparticles to target a type of immune cell...
